mitoxantrone

Examples

• All

• The benefits of mitoxantrone therapy were observed without evidence of short-term toxic effects, and treatment was generally well tolerated.

  Academic text (2002)

• We do not start mitoxantrone therapy in patients with left ventricular ejection fraction less than 50%.

  Academic text (2002)

• Several pilot trials of mitoxantrone were effective and showed no adverse events.

  Academic text (2002)

• Our observations with single-agent mitoxantrone are consistent with reports by other investigators.

  Academic text (2002)

• Mitoxantrone is the only approved therapy in the USA for all these clinical forms of multiple sclerosis.

  Academic text (2002)

• Encouraging results in open-label studies prompted this randomized trial of mitoxantrone in such patients.

  Academic text (2002)

• We believe mitoxantrone provides a new therapeutic option for patients with worsening relapsing-remitting and secondary progressive multiple sclerosis.

  Academic text (2002)

• Although decreases in left-ventricular ejection fraction were detected more frequently in mitoxantrone than in placebo groups, this difference was not significant.

  Academic text (2002)

• The primary efficacy assessment was based on experience from the pilot trial with 12 mg/m² mitoxantrone.

  Academic text (2002)

• The time to first treated relapse differed significantly between the placebo and 12 mg/m² mitoxantrone groups (p=0.0004, log-rank test).

  Academic text (2002)

Surface Forms

Etymology